is a Dutch drug delivery company and a subsidiary of Lupin Limited
since 2014. Nanomi develops and manufactures pharmaceutical products
based on particles. The proprietary and versatile microfluidic
Monosphere Technology enables the manufacturing complex injectable
products in a robust, reproducible and cost effective way, from
laboratory to commercial scale.
The company was founded in 2004 and is located in Oldenzaal, in the East of the Netherlands. Nanomi was acquired by Lupin Limited in 2014 and has been since then a proud member of the Lupin family, focusing on the development of complex injectables.
Nanomi's core technology is its proprietary Monosphere Technology based on microsieve™ emulsification. The technology enables the production of highly monodisperse droplets and particles for its use is pharmaceutical sustained release products in a robust, reproducible and cost effective way.
Our sustained release injectables offer predictable size, superior injectability and tailored release profiles.
Nanomi proudly shares the core values of the Lupin Group:
We create value through
Track-record in high complex injectable product development